Platelet biomarkers for ALS diagnosis
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study looks at blood platelets (tiny cells that help with clotting) in people with ALS and other motor neuron diseases. It aims to find new markers that could help diagnose ALS earlier. If you have a recent diagnosis, you may be able to join by giving a blood sample.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with ALS or another motor neuron disease less than 3 months ago.
- If you have ALS, your symptoms (like muscle weakness) started less than 2 years ago.
- You do not have a known genetic mutation linked to ALS.
- You are not taking blood thinners or antiplatelet drugs (except aspirin up to 160 mg per day).
- You are not pregnant or breastfeeding, and you are not under legal guardianship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for biological markers in the blood or other samples to track how ALS progresses over time. The goal is to catch changes earlier, which could help in future treatments.
This study aims to match people with ALS to potential treatments based on their genetic profile. It connects you to a network of trials that may be relevant to your specific type of ALS.
This study looks at a protein called P2X4 on immune cells in your blood to see if it can help diagnose ALS. You would give a blood sample to help researchers find a new way to identify ALS.
This study looks for early signs of ALS in people with genetic risk, healthy controls, and people with early symptoms. It aims to find markers that could help diagnose ALS sooner.
This study looks for new ways to detect and understand ALS by analyzing tiny nerve and blood markers. It may help find better treatments for ALS and related nerve diseases.
This study collects samples (blood, skin, urine) from people with ALS to create cell banks and find biomarkers. It helps researchers learn more about the disease and may lead to better treatments.
Hear when a new ALS (Amyotrophic Lateral Sclerosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.